Pain Elimination and Anxiety Control Through Experiential Virtual Reality

NCT ID: NCT06504602

Last Updated: 2024-07-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

96 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2025-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to determine if active virtual reality is more effective than passive virtual reality and standard of care distraction in decreasing pain in children, from 8 to 21 years old, undergoing intravenous placement in emergency department. The main question\[s\] it aims to answer \[is/are\]:

* Will active virtual reality reduce pain score on Faces Pain Scale - revised and measure of heart rate during intravenous placement for children ages 8 years old to 21 years old more than passive virtual reality and standard of care?
* Will active virtual reality reduce anxiety score on Visual Analog Scale - revised and measure of heart rate during intravenous placement for children ages 8 years old to 21 years old more than passive virtual reality and standard of care?

If there is a comparison group: Researchers will compare active group to passive group and standard of care.

Participants will randomized into active virtual reality, passive virtual reality or standard of care arms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Procedural Pain Procedural Anxiety

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active Virtual Reality

Within the active virtual reality group virtual environment, participants will play the game Bearblast using Oculus Go Headset for patients 8-21 years old. In BearBlast, participants travel on a pre-set path through an interactive environment.

Group Type EXPERIMENTAL

Active Virtual Reality

Intervention Type DEVICE

Active virtual reality group will play a game through a virtual environment.

Passive Virtual Reality

Within the passive virtual reality group virtual environment and age appropriate movie.

Group Type EXPERIMENTAL

Passive Virtual Reality

Intervention Type DEVICE

Passive virtual reality group will watch a movie through a virtual environment.

Standard of Care

Participants will receive standard of care distraction methods.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Active Virtual Reality

Active virtual reality group will play a game through a virtual environment.

Intervention Type DEVICE

Passive Virtual Reality

Passive virtual reality group will watch a movie through a virtual environment.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children and adolescents 8-21 years old undergoing IV placement .

* Ability to understand study procedures and to comply with them for the entire length of the study.
* Participants and caregiver speaking English or Spanish.

Exclusion Criteria

* Participants with psychiatric, developmental delay, visual or auditory deficits that would interfere with virtual reality gameplay (decision based on treating clinicians' evaluation).

* Participants receiving narcotics, opioids, or anxiolytics 8 hours prior (Tylenol and ibuprofen do not count).
* Participants with pain so significant that consent/assent is not possible (decision based on treating clinician evaluation).
* Critically ill Participants (ESI 1).
Minimum Eligible Age

8 Years

Maximum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Children's Hospital Los Angeles

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Matan Paret

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Matan Paret, MD

Role: PRINCIPAL_INVESTIGATOR

Children's Hospital Los Angeles

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Matan Paret, MD

Role: CONTACT

3233764793

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHLA-24-00171

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Little NIRVANA for Pediatric Pain and Anxiety
NCT06795126 ENROLLING_BY_INVITATION NA
Virtual Pain Care Trial
NCT05772468 ENROLLING_BY_INVITATION NA